The efficacy and safety of 2g strontium ranelate in the treatment of osteoporosis in men. A prospective multicentre, international, double-blind, placebo-controlled study with a treatment duration of 2 years and the main study analysis after 1 year.
Phase of Trial: Phase III
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Strontium ranelate (Primary)
- Indications Male osteoporosis
- Focus Therapeutic Use
- Sponsors Servier